What's breaking now, across thousands of outlets.
The occurrence of “neuropsychiatric” adverse events in testing fueled investor doubts about a drug the FDA is already reviewing for a form of epilepsy.
We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.
The genetic mutation variant has been linked to a 62 times higher risk of developing lung cancer.
The Pharmacy and Poisons Board (PPB) is stepping up efforts to keep substandard and falsified medical products out of the Kenyan market through stronger surveillance, enforcement and cross-border…
An international team led by researchers from Harvard Medical School, Brigham and Women's Hospital, and the Max Delbrück Center for Molecular Medicine in Germany has created a detailed map of the…
South Korea has brought forward its national flu vaccination programs for children and seniors after an early surge in cases, health officials said Friday.
But obesity has a more complicated relationship with the disease The post Muscle Loss is a Big Warning Sign of Dementia appeared first on Nautilus .
Mayo Clinic researchers have identified a strategy that could help chimeric antigen receptor-T cell therapy, or CAR-T cell therapy, overcome a major barrier to treating solid tumors: Cancer cells can…
